Update on completion of BTA execution by RPG Active Pharma Limited with Raghava Life Sciences Private Limited

September 15, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Corporate Relationship Department Plot No. C-1, G- Block, 25, P.J. Towers, Bandra - Kurla Complex, Bandra (East) Dalal Street, Mumbai – 400 051. Mumbai 400 001. Symbol: RPGLIFE Scrip Code: 532983 Dear Sir/Madam, Subject: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’). Further to our letter dated September 2, 2026, informing you about the execution of Business Transfer Agreement (BTA) by its wholly owned subsidiary, RPG Active Pharma Limited (RPGAP) with Raghava Life Sciences Private Limited (RLSPL) for acquisition of Active Pharmaceutical Ingredients (APIs) and intermediates Businesses as a going concern, by way of slump sale. We wish to inform you that in terms of the BTA, the said transaction has been completed, and transfer of API Business will be effective from September 16, 2026. Kindly take the same on records. Yours sincerely, For RPG Life Sciences Limited Rajesh Shirambekar Head – Legal & Company Secretary